VITALDOCTOR enables continuous patient monitoring in remote and decentralized care environments, supporting telemedicine models with real-time clinical data.
Deploying medical-grade precision to residential environments through three core telemedicine pillars.
Increase hospital capacity by managing acute patients in their own homes. Our platform integrates high-fidelity telemetry with automated alerts, mirroring the clinical rigor of an ICU from afar.
Early intervention through AI-driven symptom analysis and live clinician connectivity.
Professional home nursing care with monitoring, medication, and support.
Reduce readmission rates with proactive follow-up protocols. VITALDOCTOR detects subtle physiological shifts before they become emergencies.
Leading the transition to personalized, genomic-informed healthcare through innovation and empathy.
© 2026 VITALDOCTOR Inc. All rights reserved.
Dr. Ariane HackCMO Dr. Ariane Hack is a general practitioner and medical doctor with a Ph.D., possessing many years of experience in various medical facilities as well as in her own practice. Through her work across different healthcare settings, she has gained a broad understanding of clinical processes and the practical demands of everyday medical practice. At VITALDOCTOR, she contributes her medical expertise particularly to the validation of concepts and the development of product-oriented ideas. In addition, she oversees product and data validation, ensuring that technological solutions are aligned with real clinical needs and are practical for everyday use. |
 |
Heiner LuntzCFO Heiner Luntz is the CFO of VITALDOCTOR and has many years of experience in the financial management of companies with revenues in the hundreds of millions. He previously served as CFO at international companies with several hundred to over a thousand employees and brings extensive expertise in financial management, controlling, accounting, and corporate development. He is also a certified public accountant. At VITALDOCTOR, Heiner Luntz contributes his experience to the further development of financial structures and financial planning, as well as to strategic issues related to growth and financing. His many years of experience working within large corporate structures provide the team with sound financial insights. |
 |
Markus WiegmannCSO As a highly experienced manager with over 30 years in the medtech industry, Markus Wiegmann brings a wealth of experience to VITALDOCTOR. After holding positions at companies such as aap Implantate and ulrich medical, he most recently spent over 20 years at Stryker Corporation, a leading global medtech group with annual revenue of approximately $25 billion. There, among other roles, he held a leadership position in strategic corporate development and M&A and was responsible for the integration and acquisition of new companies and technologies to support Stryker’s strategic corporate development. Most recently, he served as Managing Director for the DACH region and Poland. In addition, as an elected board member of BVMed, he was actively involved in the German healthcare industry. |
 |
Dr. Konstantin SchönbornBeiratsvorsitzender Dr. Konstantin Schönborn studied law at the universities of Würzburg, Madrid, and Kiel, and earned his doctorate in Kiel. He has been a partner at Pava Partners since 2005 and has over 20 years of M&A experience in the medical technology sector. Thanks to his outstanding network in this sector, he is able to open doors for German-speaking companies to globally active medtech corporations. Dr. Konstantin Schönborn serves on the advisory boards of several companies in Germany and Austria. |
 |
Jonathan BotchouaCEO Jonathan Botchoua is the co-founder and CEO of VITALDOCTOR GmbH and a national award winner in mathematics in Germany. He has a background in electrical engineering and is also a software and AI developer, specializing in data processing, analysis, and the design and visualization of complex systems and data-driven applications. At VITALDOCTOR, he is responsible for the company’s strategic direction as well as the development and scaling of digital health solutions. This includes, in particular, the establishment and further development of the business model, the management of core business processes, and the operational implementation at the intersection of technology, medicine, and regulation. |
 |